Integra LifeSciences Holdings Cost of Goods Sold 2010-2024 | IART

Integra LifeSciences Holdings cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Integra LifeSciences Holdings Annual Cost of Goods Sold
(Millions of US $)
2023 $657
2022 $587
2021 $598
2020 $521
2019 $565
2018 $571
2017 $436
2016 $349
2015 $327
2014 $303
2013 $280
2012 $314
2011 $299
2010 $268
2009 $245
Integra LifeSciences Holdings Quarterly Cost of Goods Sold
(Millions of US $)
2024-09-30 $181
2024-06-30 $192
2024-03-31 $162
2023-12-31 $171
2023-09-30 $164
2023-06-30 $174
2023-03-31 $148
2022-12-31 $148
2022-09-30 $148
2022-06-30 $148
2022-03-31 $143
2021-12-31 $156
2021-09-30 $144
2021-06-30 $151
2021-03-31 $146
2020-12-31 $147
2020-09-30 $135
2020-06-30 $105
2020-03-31 $133
2019-12-31 $149
2019-09-30 $143
2019-06-30 $144
2019-03-31 $129
2018-12-31 $146
2018-09-30 $143
2018-06-30 $138
2018-03-31 $144
2017-12-31 $148
2017-09-30 $102
2017-06-30 $99
2017-03-31 $87
2016-12-31 $85
2016-09-30 $89
2016-06-30 $90
2016-03-31 $85
2015-12-31 $90
2015-09-30 $86
2015-06-30 $75
2015-03-31 $75
2014-12-31 $60
2014-09-30 $74
2014-06-30 $87
2014-03-31 $82
2013-12-31 $36
2013-09-30 $82
2013-06-30 $82
2013-03-31 $80
2012-12-31 $82
2012-09-30 $80
2012-06-30 $78
2012-03-31 $75
2011-12-31 $83
2011-09-30 $79
2011-06-30 $73
2011-03-31 $65
2010-12-31 $71
2010-09-30 $69
2010-06-30 $64
2010-03-31 $63
2009-12-31 $64
2009-09-30 $63
2009-06-30 $60
2009-03-31 $58
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.675B $1.542B
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $197.634B 24.11
Intuitive Surgical (ISRG) United States $186.606B 97.56
Edwards Lifesciences (EW) United States $43.604B 27.69
Alcon (ALC) Switzerland $41.521B 27.78
IQVIA Holdings (IQV) United States $34.761B 19.15
IDEXX Laboratories (IDXX) United States $33.493B 39.44
DexCom (DXCM) United States $29.615B 44.60
Waters (WAT) United States $21.413B 31.66
STERIS (STE) Ireland $20.170B 23.22
SONOVA HOLDING (SONVY) Switzerland $19.359B 0.00
Hologic (HOLX) United States $16.058B 17.34
Fresenius Medical Care AG KGaA (FMS) Germany $13.192B 13.54
Sysmex ADR (SSMXY) Japan $11.726B 36.77
Globus Medical (GMED) United States $11.158B 28.25
Penumbra (PEN) United States $9.346B 91.55
Masimo (MASI) United States $9.102B 44.04
Teleflex (TFX) United States $8.118B 12.95
Glaukos (GKOS) United States $7.925B 0.00
Integer Holdings (ITGR) United States $4.457B 25.26
PROCEPT BioRobotics (PRCT) United States $4.215B 0.00
Inari Medical (NARI) United States $3.185B 0.00
Veracyte (VCYT) United States $3.028B 90.86
Nihon Kohden (NHNKY) Japan $2.590B 19.67
LivaNova (LIVN) United Kingdom $2.579B 14.89
Tandem Diabetes Care (TNDM) United States $2.185B 0.00
Elekta AB (EKTAY) Sweden $2.096B 18.84
TransMedics (TMDX) United States $2.031B 64.39
RxSight (RXST) United States $1.539B 0.00
Alphatec Holdings (ATEC) United States $1.255B 0.00
Artivion (AORT) United States $1.173B 77.69
Pulse Biosciences (PLSE) United States $1.094B 0.00
OPKO Health (OPK) United States $1.072B 0.00
Paragon 28 (FNA) United States $0.820B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.760B 12.92
Mesa Laboratories (MLAB) United States $0.714B 16.83
IRadimed (IRMD) United States $0.676B 36.54
ORTHOFIX MEDICAL INC (OFIX) United States $0.657B 0.00
AxoGen (AXGN) United States $0.654B 0.00
Semler Scientific (SMLR) United States $0.568B 29.92
SiBone (SIBN) United States $0.547B 0.00
OrthoPediatrics (KIDS) United States $0.547B 0.00
Pacific Biosciences Of California (PACB) United States $0.529B 0.00
Treace Medical Concepts (TMCI) United States $0.430B 0.00
Tactile Systems Technology (TCMD) United States $0.407B 22.01
ClearPoint Neuro (CLPT) United States $0.404B 0.00
Delcath Systems (DCTH) United States $0.357B 0.00
AngioDynamics (ANGO) United States $0.349B 0.00
NeuroPace (NPCE) United States $0.333B 0.00
CVRx (CVRX) United States $0.284B 0.00
Alpha Tau Medical (DRTS) Israel $0.219B 0.00
Inogen (INGN) United States $0.198B 0.00
Accuray (ARAY) United States $0.180B 0.00
Sight Sciences (SGHT) United States $0.171B 0.00
KORU Medical Systems (KRMD) United States $0.170B 0.00
Nevro (NVRO) United States $0.135B 0.00
Atossa Genetics (ATOS) United States $0.123B 0.00
Sensus Healthcare (SRTS) United States $0.118B 12.65
Spectral Diagnostics (EDTXF) Canada $0.094B 0.00
LENSAR (LNSR) United States $0.087B 0.00
Monogram Orthopaedics (MGRM) United States $0.086B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
InspireMD (NSPR) Israel $0.078B 0.00
Vicarious Surgical (RBOT) United States $0.071B 0.00
Hyperfine (HYPR) United States $0.068B 0.00
908 Devices (MASS) United States $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.066B 0.00
WORK Medical Technology Group (WOK) China $0.058B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
EnVVeno Medical (NVNO) United States $0.044B 0.00
Rapid Micro Biosystems (RPID) United States $0.043B 0.00
Neuronetics (STIM) United States $0.039B 0.00
Envoy Medical (COCH) United States $0.037B 0.00
Spectral AI (MDAI) United States $0.035B 0.00
Precision Optics (POCI) United States $0.033B 0.00
NexGel (NXGL) United States $0.031B 0.00
Accelerate Diagnostics (AXDX) United States $0.030B 0.00
Adagio Medical Holdings (ADGM) United States $0.027B 0.00
DarioHealth (DRIO) United States $0.025B 0.00
Biosig Technologies (BSGM) United States $0.022B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Baird Medical Investment Holdings (BDMD) $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.008B 0.00
T2 Biosystems (TTOO) United States $0.007B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
Check-Cap (CHEK) Israel $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00